GlassScriptPhysician profile
William H Rossy
NPI 1548262272
$3,658.81
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $619 · 2020: $280 · 2021: $412 · 2022: $26.29 · 2023: $2,322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,250 · Food and Beverage: $71.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,250.00 |
| Food and Beverage | $71.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $2,250.00 | 2023 | |
| Novo Nordisk INC | $250.35 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $199.75 | 2019-2021 | |
| Glaxosmithkline, LLC. | $109.56 | 2019-2021 | |
| Amgen INC. | $108.40 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $95.75 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $82.76 | 2019-2020 | |
| Pfizer INC. | $66.44 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $58.07 | 2021-2023 | Tricera Handpiece |
| Abbvie INC. | $56.74 | 2019-2022 | |
| Amarin Pharma, INC. | $56.33 | 2019-2021 | |
| Smith+Nephew, INC. | $49.14 | 2019 | |
| Depuy Synthes Sales INC. | $48.55 | 2019-2020 | |
| Stryker Corporation | $43.70 | 2023 | Cobra |
| Daiichi Sankyo INC. | $29.96 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Topcon Healthcare Solutions, INC. | $29.48 | 2020 | |
| Sanofi Pasteur INC. | $28.05 | 2019 | |
| Janssen Pharmaceuticals, INC | $26.92 | 2019 | |
| Lilly USA, LLC | $26.83 | 2021 | |
| Ferring Pharmaceuticals INC. | $14.71 | 2019 | |
| Sanofi-Aventis U.S. LLC | $14.47 | 2021 | |
| Genentech USA, INC. | $12.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Rossy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.